Understanding the Challenges of Medical Device Reprocessing - ASP Learning Lab
Understanding the Challenges of Medical Device Reprocessing

Understanding the Challenges of Medical Device Reprocessing

Carlos Palos Md, Prof. Francesco Venneri, Prof. Jon Otter, Mrs. Moya Alexander, Mrs. Soraia Pedroso, Eng. Jonathan Hart

Create a free account to access all information

Healthcare-associated infections (HAI) remain the most common adverse event in care delivery,¹ affecting an estimated 3.7 million patients in Europe each year, with surgical site infections (SSI) accounting for 18.3% of cases.² **SSI alone adds thousands of euros in costs and extra hospital days per patient.**³

Effective device decontamination — spanning cleaning, disinfection, packaging, and sterilization — is essential to prevention, yet each stage carries risk of error.⁴ The decades-old Spaulding classification struggles with today’s complex devices;⁵ robotic instruments, with multiple articulation points and channels that resist disassembly, are especially difficult to clean, leaving residual bioburden that raises infection risk.⁶

High-level disinfection (HLD) … has proven insufficient: a meta-analysis of over 13,000 samples found 16.14% of “patient-ready” duodenoscopes remained contaminated after HLD alone,⁷ driving a shift toward sterilization as the new benchmark for endoscope reprocessing.⁸ Yet high-temperature steam sterilization can degrade heat-sensitive instruments, with one facility projected to spend over $1 million on avoidable repairs over a decade.⁹ Ethylene oxide and formaldehyde gas carry their own risks, both classified as carcinogenic to humans.¹⁰

Hydrogen peroxide gas plasma sterilization addresses these gaps, delivering significantly lower failure rates than vaporized hydrogen peroxide sterilization¹¹ with rapid, residue-free, low-emission processing for heat-sensitive devices.¹²

 

Inside the eBook, you’ll learn about:

  • The scale and clinical/financial cost of healthcare-associated and surgical site infections
  • Why the 50-year-old Spaulding classification may fall short for modern, complex medical devices
  • Reprocessing challenges specific to robotic and minimally invasive surgical instruments
  • Why high-level disinfection is increasingly insufficient to prevent endoscope-related outbreaks
  • The risks and trade-offs of steam, ethylene oxide, formaldehyde, and low-temperature sterilization methods
  • The shared responsibility of device manufacturers, sterilizer manufacturers, and healthcare professionals in instrument validation
  • How hydrogen peroxide gas plasma sterilization addresses these unmet reprocessing needs

Reasons to download the eBook

  • Understand the true clinical and financial cost of inadequate medical device reprocessing
  • Learn why legacy classification systems may no longer fit today’s complex instruments
  • Access data-backed comparisons of sterilization methods on safety, cost, and environmental impact
  • Review real-world outbreak case studies tied to reprocessing failures
  • Discover how hydrogen peroxide gas plasma sterilization can reduce infection risk and long-term costs

Authors

  • Francesco Venneri

    Francesco Venneri

    Prof.

    Clinical Risk Manager and Patient Safety Officer

  • Jon Otter

    Jon Otter

    Prof.

    Honorary Senior Lecturer in HCAI AMR

  • Moya Alexander

    Moya Alexander

    Mrs.

    Decontamination Lead

  • Soraia Pedroso

    Soraia Pedroso

    Mrs.

    Clinical Nurse Specialist/ Lead Infection Prevention and Control

  • Jonathan Hart

    Jonathan Hart

    Eng.

    Head of Technological Innovation and Health Technology Assessment

  • Carlos Palos

    Carlos Palos

    Md

    Internal Medicine & Intensive Care Specialist Infection Control & Antimicrobial Stewardship

References

  1. Global guidelines for the prevention of surgical site infection, second edition. Geneva: World Health Organization; 2018.
  2. Suetens, C., Latour, K., Kärki, T., et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill, 2018;23.
  3. Badia, J.M., Casey, A.L., Petrosillo, N., et al. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect, 2017;96:1–15.
  4. Decontamination and reprocessing of medical devices for health-care facilities. Geneva: World Health Organization; 2016.
  5. Rutala, W.A., & Weber, D.J. Disinfection and sterilization: an overview. Am J Infect Control, 2013;41:S2–5.
  6. Healthcare Purchasing News. Managing the Reprocessing Challenges of Robotic Instruments. Accessed 19/08/2021.
  7. Larsen, S., Russell, R.V., Ockert, L.K., et al. Rate and impact of duodenoscope contamination: A systematic review and meta-analysis. EClinicalMedicine, 2020;25.
  8. U.S. Food & Drug Administration. Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling. 2015.
  9. McCreanor, V., & Graves, N. An economic analysis of the benefits of sterilizing medical instruments in low-temperature systems instead of steam. Am J Infect Control, 2017;45:756–760.
  10. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Agents classified by the IARC Monographs, Volumes 1–129.
  11. Rutala, W.A., Gergen, M.F., Sickbert-Bennett, E.E., et al. Comparative evaluation of the microbicidal activity of low-temperature sterilization technologies to steam sterilization. Infect Control Hosp Epidemiol, 2020;41:391–395.
  12. Advanced Sterilization Products. STERRAD™ 100NX Sterilization System with ALLClear™ Technology User’s Guide. A11150401-50.